Solid Biosciences earnings were -$207.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest SLDB earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$54.8M, down 3.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SLDB reported annual earnings of -$174.3M, with 39.8% growth. The next SLDB earnings date is Nov 2, 2026.
What were Solid Biosciences's earnings last quarter?
On SLDB's earnings call on Aug 11, 2026, Solid Biosciences (NASDAQ: SLDB) reported Q2 2026 earnings per share (EPS) of -$0.38, up 9.52% year over year. Total SLDB earnings for the quarter were -$54.80 million. In the same quarter last year, Solid Biosciences's earnings per share (EPS) was -$0.42.
The next SLDB earnings date is Nov 2, 2026. Add SLDB to your watchlist to be reminded of Solid Biosciences's next earnings date.
Is Solid Biosciences profitable or losing money?
As of the last Solid Biosciences earnings report, Solid Biosciences is currently losing money. Solid Biosciences's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$207.10 million, a 34.41% increase year over year.
What was SLDB's earnings growth in the past year?
As of Solid Biosciences's earnings date in Aug 11, 2026, Solid Biosciences's earnings has grown year over year. SLDB earnings in the past year totalled -$207.10 million.
What are Solid Biosciences's earnings expectations?
The current EPS estimate for Solid Biosciences's earnings report in Nov 2, 2026 is -$0.37.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.